title: Phase I study of the somatostatin analogue somatuline in refractory small-cell lung carcinoma.
authors.forename: C
authors.initials: C
authors.lastname: Cotto
authors.forename: E
authors.initials: E
authors.lastname: Quoix
authors.forename: F
authors.initials: F
authors.lastname: Thomas
authors.forename: S
authors.initials: S
authors.lastname: Henane
authors.forename: V
authors.initials: V
authors.lastname: Trillet-Lenoir
mesh_terms: D018288:Carcinoma, Small Cell / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D015282:Octreotide / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D010456:Peptides, Cyclic; D013004:Somatostatin / Q000031:analogs & derivatives*; D016896:Treatment Outcome
chemical_list: D010456:Peptides, Cyclic; C060347:lanreotide; D013004:Somatostatin; D015282:Octreotide